The Current Health Crisis Has Created a $250 Billion Telehealth Opportunity in the U.S.

Here’s Why CloudMD Software & Services Inc. USA (DOCRF) CANADA (DOC) Could Become the Next Teladoc Health, as it Quickly Expands Across North America

With the worst global health crisis of our lifetime showing no signs of slowing, the massive $11.9 trillion health care industry is undergoing a massive revolution.⁽¹⁾

Along the way, it’s creating a QUARTER TRILLION DOLLAR opportunity for Canadian-based companies like CloudMD Software & Services Inc. USA (DOCRF) CA (DOC).⁽²⁾

The very same opportunity that sent shares of Teladoc Health from approximately $10 to approximately $253 in less than four years.

All thanks to the rise of telehealth – a high-tech shift into the world of virtual healthcare.

With the global health crisis only getting worse, telehealth has exploded.

In fact, U.S. doctors are on track to log more than a billion visits by the end of this year alone.⁽³⁾

However, they could see far more than that.

A recent poll says approximately 76% of consumers say they’re moderately or highly interested in using telehealth as compared to 11% in 2019, according to McKinsey & Co.⁽⁴⁾

After all, with telehealth:

• We don’t always have to travel to a doctor’s office
• There’s no need to take time off of work and travel to and from the doctor’s office
• There are now plenty of on-demand healthcare solutions at your fingertips
• There’s plenty of access to a myriad of quality doctors, specialists and allied health professionals
• There’s less chance of catching a virus by avoiding crowded waiting rooms and ER’s
• There’s less time in the waiting room, unless there’s a critical health issue

And it’s BIG BUSINESS.

So much so, analysts at Frost & Sullivan say the industry could grow sevenfold by 2025 – a five-year compound growth rate of 38.2%.⁽⁵⁾

“The critical need for social distancing among physicians and patients will drive unprecedented demand for telehealth, which involves the use of communication systems and networks to enable either a synchronous or asynchronous session between the patient and provider,” said Victor Camlek, healthcare principal analyst at Frost & Sullivan.⁽⁶⁾

Even more impressive…big investments are just beginning to flood into the sector.

One company that’s seen monster growth to date is Teladoc Health, whose stock exploded from approximately $60 to approximately $253 a share in the last year.

That’s an increase of about 322% in less than a year.

Or take a look at 1Life Healthcare Inc., whose stock ran from approximately $15 to approximately $43 a share just this year.

While these are impressive increases to date, there are other, far more inexpensive opportunities out there, just now benefiting from a potential $250 billion market boom.

One of the top telehealth stocks to be well aware of could be the next big winner in the space

We’ve uncovered a pure-play telehealth stock that’s severely undervalued as compared to Teladoc Health and. WELL Health Technologies…

That company is CloudMD Software & Services Inc. USA (DOCRF) CA (DOC).

At just $1.65 a share, it’s already showing signs of big growth.

In the first quarter of 2020, revenue rocketed 178% year over year to nearly $3.1 million.⁽⁷⁾

By the second quarter of 2020, revenue was up 163% year over year to $2.8 million with gross margins of 42%. Better yet, out of the gate, it’s network includes 14 clinics, 64 physicians, 35 specialists and allied health professionals servicing nearly 500,000 patients⁽⁸⁾

Here’s Why CloudMD Software & Services USA (DOCRF) CANADA (DOC) Could be the Next Teladoc Health

1. It’s already providing services to approximately 500,000 patients⁽⁹⁾
2. Revenue growth is off the charts with Q1 year over year growth of 178%, and Q2 year over year growth of 163%.
3. It has over C$30million in cash and is well-positioned for long-term growth and is prepared to deliver high returns to investors.⁽¹⁰⁾
4. It’s very well-funded for its expansion across North America. It’s also executing an exciting, very strong M&A pipeline.
5. It offers both physical and mental virtual health care
6. It’s significantly undervalued as compared to its peers
7. Best of all, patients don’t have to leave their homes for health visits anymore

Better still, if you take a look at WELL Health Technologies and Teladoc Health, investors can clearly see what’s possible, as telehealth companies expand in Canada and throughout the U.S.

Far more impressive — One of the key differences CloudMD has over some of its competitors is that the Company provides such tools to the market on BOTH the consumer (B2C) and enterprise (B2B) sides of the industry, so it’s a win-win for everyone.

Plus, CloudMD is focused on rapidly increasing its patient base by onboarding clinics, increasing its physician network, direct-to-consumer advertising and through new telemedicine kiosk partnerships with high traffic pharmacies. All of these tools are ultimately building a virtual healthcare practice, continuity of care and patient centric practices.

CloudMD is also set to make a big splash with its enterprise telemedicine software, Livecare

Livecare Connect, which is a telemedicine platform used by physicians across North America, including a strategic partnership in the United States.

In addition, Livecare has been added to preferred vendor lists of leading Government associations across Canada which represent over 20,000 practitioners.

The platform also offers:

• Streamlined records management, scheduling, consultations and appointments
• Secure engagement between providers & patients
• A continuum of quality care across branches of medicine
• Tools to manage administrative tasks far more efficiently

But this is just the beginning of a much bigger story.

One that could create a real winner, just like Teladoc Health has been.

• CloudMD is a pure-play on the QUARTER TRILLION DOLLAR telehealth boom
• CloudMD is an early-mover with big expansion plans in Canada and in the U.S.
• Currently trades for approximately $1.65 a share

In short, with a once in a lifetime healthcare boom, investors are being handed a potential goldmine, and severely undervalued opportunity with CloudMD.

The Market is Still Undervaluing the CloudMD USA (DOCRF) CANADA (DOC) Stock

As volatile as 2020 has been, Teladoc Health has increased approximately 142% year to date.

Year to date, 1Life Healthcare has increased approximately 61%. WELL Health Technologies has increased approximately 316%. Those are some big wins in a relatively short period of time.

But it comes as no surprise.

This can quickly happen to a stock caught in a QUARTER TRILLION DOLLAR telehealth boom.

For a company like CloudMD, there’s still PLENTY of similar room to grow

That’s especially true as it builds a sizable footprint in North America.

In fact, since acquiring Livecare in early 2020, CloudMD has been added to the approved vendor lists with some of the biggest healthcare providers in Canada including:⁽¹¹⁾

• Doctors of BC
• BC Optometry Association
• BC Centre for Ability
• British Columbia Chiropractic Association
• OntarioMD
• Ontario Association of Optometrists
• Canadian Association of Occupational Therapists
• And many more…

Together, these organizations represent approximately 20,000+ practitioners.⁽¹²⁾

In addition, CloudMD has seen dramatic growth, with 3600 practitioners now using the platform and almost 3 million patient charts.

That’s just in Canada.

Through a Value Added Reseller Agreement with ISYA4, CloudMD Software & Services USA (DOCRF) CA (DOC) is entering the red-hot U.S. market.

With that IDYA4 will resell CloudMD’s Livecare technology to U.S. clients, quickly expanding services throughout the North American market.

Plus, with an extensive, established client network, IDY4A could add big value to CloudMD expansion plans. IDY4A’s client list includes:

• The Bureau of Justice Assistance,
• U.S. Department of Justice,
• U.S. Department of Homeland Security,
• U.S. Health and Human Services,
• Centers for Disease Control,
• Experis US (Manpower Group)
• Deloitte

CloudMD USA (DOCRF) CANADA (DOC) Growth is Also Fueled by Impressive M&A

In August 2020, the company announced its acquisition of a profitable seven location rehabilitation clinic network with $5.8 million in annual revenue.

CloudMD also signed an agreement to acquire majority interest in West Mississauga Medical Clinic, which is already cash flow positive with revenue of $1.8 million.

It also recently announced its intent to acquire a U.S. based chronic care medical clinic to capitalize a massive multi-trillion-dollar chronic mental health disease market. According to the CDC, 90% of the US $3.5 trillion spent annually on healthcare is spent on people with chronic mental health diseases.⁽¹³⁾

And it acquired the South Surrey Medical Clinic, which services approximately 60,000 patients and already uses online booking, EMR software and telemedicine that will be easily integrated into CloudMD’s software and clinic network.

Recent M&A Gives CloudMD USA (DOCRF) CANADA (DOC) Exposure to a $36.3 Billion Market

In July 2020, CloudMD USA (DOCRF) CA (DOC) also announced it’s intent to acquire of Snapclarity Inc., an enterprise mental heal platform that will allow the company to expand into mental wellness, too.

“The COVID-19 pandemic is the most serious public health emergency of our lifetime and it has further deepened the mental health crisis we were already facing,” said Dr. Essam Hamza, CEO of CloudMD. Recent data tells us that over 56% of Canadians said the pandemic is having a negative impact on their mental health, with social isolation being the top contributing factor. This acquisition of Snapclarity is a transformational addition to CloudMD as we continue to strengthen our suite of virtual care solutions and make it easier for Canadians to get help from home. As a primary care physician for the past 20 years the importance of providing a viable tool for the mental health crisis is a deeply personal motivation for me.”⁽¹⁴⁾

Helping a bit more, the telepsychiatry market is estimated to be valued at approximately $36.3 billion by 2027.⁽¹⁵⁾

“According to the National Institute of Mental Health, in 2018 one in five adults in U.S. had a mental illness. There has been a significant rise in telemental health visits over the past decade in the developed countries such as U.S., U.K., Germany, and Spain and the trend is expected to continue during the forecast period, thereby contributing to the adoption of virtual mental health consultation by hospitals and healthcare settings.”⁽¹⁵⁾

CloudMD USA (DOCRF) CANADA (DOC) Management Was Built by Physicians

Dr. Essam Hamza, MD – Chief Executive Officer

Dr. Hamza completed his MD and Family Practice degree at the University of Alberta in 1999. He founded HealthVue in 2005 and grew the business to include four interconnected high-tech clinics serving over 100,000 patients. He also has extensive capital markets experience, taking private companies public and sitting on public company boards.

Dr. Amit Mathur, OD – President

Dr. Amit Mathur has nearly 20 years of health experience as an optometrist and entrepreneur. He cofounded Omni & Vision, a multi-location eye care clinic group and has been a consultant- lecturer to several pharma companies and participated on their Advisory panels. He also cofounded Livecare, a pioneer company in Telehealth.

Dr. David Ostrow, MD, BSc., MA, FRCPC – Chief Medical Officer

Dr. David Ostrow was President and CEO of Vancouver Coastal Health and previously held progressively senior roles at VGH and Fraser Health. He currently is an Emeritus Professor of Medicine at UBC. He was the founding Medical Director of the BC Transplant Society/VGH’s Lung Transplant Program and was active in the founding of the Pulmonary Hypertension Clinic. He is the author/co-author of over 90 publications and continues to consult on matters of health policy & economics, technology and genomics.

Dr. Sohal Goyal – Director, Corporate Development

Dr. Sohal Goyal is a respected healthcare thought leader in Ontario and over his 18-year career has established a vast network of healthcare relationships. Dr. Goyal graduated from the University of Toronto Faculty of Medicine and is a Fellow of the College of Family Physicians. He is an assistant clinical professor with McMaster University Department of Family Medicine and is currently the Lead Physician of one of the largest Family Health Groups, which includes over 130 physicians. Dr. Goyal has held numerous leadership roles with the Ontario Medical Association and is currently chair of both District 5 and the local Primary Care Network. In addition, he has acted as an advisor for many public and private companies.

 

 

Disclaimer

Privacy Policy